Liliana Valvano, LMSW, an associate in Psychiatric Social Work at Columbia University Irving Medical Center, works with neurodivergent clients, helping them build rich and fulfilling lives.
Psychiatrist and eating disorders researcher Joanna Steinberg receives 100K from Huberman Lab Podcast to further work on brain-based differences linked to the disorder.
Lisa Ranzenhofer, a clinical psychologist and researcher, discusses the hallmarks of binge eating disorder, its prevalence, possible causes, and treatments.
“The college years represent a distinct period in which there is a critical need to improve early identification and treatment for debilitating mental disorders,” wrote Dr. Randy P. Auerbach.
A review of Dr. Eric Kandel's engaging new overview of contemporary thinking on the intersection of mental health and neuroscience, "The Disordered Mind: What Unusual Brains Tell Us About Ourselves."
“This study strongly indicates the feasibility of using multimodal MRI—particularly diffusion MRI–based analysis of the structural connectome—to accurately predict Alzheimer’s risk,” said Jiook Cha.
“Mitochondria are the missing link between our psychological state and neurological or other disorders involving inflammation,” says Dr. Martin Picard.
“A good deal of the demonization of people with mental disorders stems from a marked overestimation of their risk of violence,” says Dr. Paul Applebaum.
Dr. Sander Markx and Dr. Job de Jong are hoping their work on mini brains could lead to a pioneering study using stem cells to find and test new treatments for psychiatric disorders.
Kristina Denisova, PhD specializes in state of the art brain imaging of children at risk for Autism Spectrum Disorders (ASD) at Columbia University Irving Medical Center.
The Columbia Suicide Severity Rating Scale (C-SSRS) was primarily developed Dr. Kelly Posner as a tool to screen for suicidality in medication research trials.
“We are thrilled about our new partners and the opportunity to apply our biotechnology platform at the scale needed to identify new drugs for neuropsychiatric disorders,” said Dr. Sean Escola.